Current Radiopharmaceuticals
Title:Editorial (Hot Topic: Radionuclide Generators – A New Renaissance in the Development of Technologies to Provide Diagnostic and Therapeutic Radioisotopes for Clinical Applications)
Volume: 5 Issue: 3
Author(s): F. F. (Russ) Knapp and R. P. Baum
Affiliation:
Export Options
About this article
Cite this article as:
F. (Russ) Knapp F. and P. Baum R., Editorial (Hot Topic: Radionuclide Generators – A New Renaissance in the Development of Technologies to Provide Diagnostic and Therapeutic Radioisotopes for Clinical Applications), Current Radiopharmaceuticals 2012; 5 (3) . https://dx.doi.org/10.2174/1874471011205030175
DOI https://dx.doi.org/10.2174/1874471011205030175 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Latest Insights into the Anticancer Activity of Gold(III)-Dithiocarbamato Complexes
Anti-Cancer Agents in Medicinal Chemistry CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
Current Cancer Drug Targets N-Heterocyclic Dronic Acids: Applications and Synthesis
Mini-Reviews in Medicinal Chemistry Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment
Current Signal Transduction Therapy Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment
Current Neuropharmacology Classical to Current Approach for Treatment of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets BK Polyoma Virus Nephropathy in an Immunocompromised Host
New Emirates Medical Journal Ceramide in Chemotherapy of Tumors
Recent Patents on Anti-Cancer Drug Discovery Exogenous Expression of WNT7A in Leukemia-Derived Cell Lines Induces Resistance to Chemotherapeutic Agents
Anti-Cancer Agents in Medicinal Chemistry Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies
Current Pharmacogenomics and Personalized Medicine Drug Delivery for Cancer Immunotherapy and Vaccines
Pharmaceutical Nanotechnology An Approach to Whole-Genome Identification of IRES Elements
Current Genomics The Use of Lentinan for Treating Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry Lung Cancer Chemotherapy, New Treatment and Related Patents
Recent Patents on Anti-Cancer Drug Discovery Production of Lentivectors for Clinical Use
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) CADA, a Potential Anti-HIV Microbicide that Specifically Targets the Cellular CD4 Receptor
Current HIV Research The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells
Current Drug Targets From the Deepest Sea Shelf to the Uppermost Kitchen Cabinet Shelf: The Quest for Novel TNF-α Inhibitors
Current Topics in Medicinal Chemistry Tumor Immune Escape Mechanisms that Operate During Metastasis
Current Pharmaceutical Biotechnology The Role of the Transcription Factor E2F1 in Hepatocellular Carcinoma
Current Drug Delivery